Company news

Personalis, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Personalis Announces Issuance of US Patents Related to the Exome-Wide NeXT Liquid Biopsy Platform

October 25, 2021

Personalis to Announce Third Quarter Financial Results on November 4, 2021

October 20, 2021

Personalis Expands Leadership Team With Appointment of Robert Bruce, Vice President of Reimbursement

October 12, 2021

Mayo Clinic Collaborates With Personalis Inc. to Expand Cancer Genomic Testing

October 11, 2021

Personalis Receives New VA MVP Task Order and Record Quarterly Orders From Oncology Customers; Reconfirms Total Revenue Outlook for 2021 with Further Accelerated Oncology Growth

September 17, 2021

Personalis to Participate at the Morgan Stanley 19th Annual Global Healthcare Conference

August 25, 2021

Personalis Announces Corporate Headquarters Expansion to Accelerate Growth in Laboratory Operations and Research & Development

August 24, 2021

Personalis Reports Second Quarter 2021 Financial Results

August 3, 2021

Personalis to Participate at the 6th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference

August 2, 2021

Personalis, Inc. Publishes New Data Demonstrating a Novel Composite Biomarker NEOPS™ for Predicting Response to Cancer Immunotherapy in Late-Stage Melanoma Patients

August 1, 2021

Personalis to Announce Second Quarter Financial Results on August 4, 2021

July 20, 2021

Personalis Announces NeXT Level Biomarkers Symposium

June 21, 2021

Personalis Announces Delivery of the 125,000th Genome to the U.S. Department of Veterans Affairs Million Veteran Program

June 1, 2021

Personalis to Participate at the Oppenheimer MedTech, Tools & Diagnostics Summit

May 17, 2021

Personalis, Inc. to Present at Biomarkers Week Online 2021

May 16, 2021

Personalis Reports First Quarter 2021 Financial Results

May 4, 2021

Personalis to Present at the 2021 Bank of America Healthcare Conference

April 28, 2021

Personalis to Report First Quarter 2021 Financial Results on May 5, 2021

April 20, 2021

Personalis Presents Data at AACR Annual Meeting 2021 Showcasing the Personalis ImmunoID NeXT Platform®

April 7, 2021

Personalis Announces Collaboration with MapKure to Use Personalis’ NeXT Platform™ for Clinical Trials and Companion Diagnostic Development

March 28, 2021

Personalis Announces Changes to its Board of Directors

March 7, 2021

Personalis Reports Fourth Quarter and Full Year 2020 Financial Results

February 24, 2021

CORRECTING and REPLACING Personalis to Report Fourth Quarter 2020 Financial Results on February 25, 2021

February 21, 2021

Natera and Personalis Partner for Personalized Monitoring in Oncology

February 16, 2021

Personalis to Report Fourth Quarter 2020 Financial Results on February 25, 2021

February 10, 2021

Personalis Expands Leadership Team with Appointment of Susan Moriconi, VP of People and Chief Human Resources Officer

February 7, 2021

Personalis to Present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference

February 3, 2021

Personalis Announces Pricing of Public Offering of Common Stock

January 25, 2021

Personalis Announces Launch of Public Offering of Common Stock

January 25, 2021

Personalis Reports Preliminary Fourth Quarter 2020 Revenue

January 10, 2021

Personalis to Present at the 23rd Annual Needham Virtual Growth Conference

December 27, 2020

Personalis Announces the Launch of SHERPA™ for High-Accuracy Neoantigen Prediction and Cancer Diagnostic Biomarker Development

December 16, 2020

Personalis Announces the Launch of NEOPS™, a Neoantigen-based Composite Biomarker for Cancer Immunotherapy Response

December 16, 2020

Personalis Announces Delivery of the 100,000th Genome to the U.S. Department of Veterans Affairs Million Veteran Program

December 8, 2020

Personalis, Inc. to Present at EACR Liquid Biopsies Virtual Event

November 17, 2020

Personalis® to Present at the AMP Annual Meeting 2020

November 15, 2020

Personalis, Inc. to Present New Data at the Society for Immunotherapy of Cancer (SITC) 35th Annual Meeting

November 8, 2020

Personalis Reports Third Quarter 2020 Financial Results

November 4, 2020

Personalis to Announce Third Quarter 2020 Financial Results on November 5, 2020

October 21, 2020

Personalis to Participate in Immuno Series US Virtual Meeting

October 14, 2020

Personalis, Inc. to Present at IO Combinations 360˚

September 30, 2020

Personalis to Participate in Digital World CB & CDx Meeting

September 28, 2020

Personalis Receives Contract Extension and New Task Order From the VA’s Million Veteran Program – Total Awarded to Date Now $175M

September 16, 2020

Personalis Strengthens Commercial Team with the Appointment of New Head of Population Genomics

September 14, 2020

Personalis to Participate at the Needham Virtual Cancer Diagnostics 1x1 Conference

August 11, 2020

Personalis Reports Second Quarter 2020 Financial Results

August 5, 2020

Personalis, Inc. Launches NeXT Liquid Biopsy™, A High-Performance, Exome-Wide Liquid Biopsy Platform

August 2, 2020

Personalis to Announce Second Quarter 2020 Financial Results on August 6, 2020

July 22, 2020

Personalis Further Expands Leadership Team With Appointment of Leslie Grab, VP of Intellectual Property and John Lyle, VP of Assay Research and Development

July 15, 2020

Personalis Completes Sequencing 75,000th Whole Human Genome for VA MVP

June 23, 2020

← Newer news releases · Older news releases →

Calls

The 5 newest of 18 calls. Every call is listed under its year.

Decks